CDMO Orthopedic Market: Spinal Innovation, Regulation, and Regional Outsourcing Dynamics

While hip and knee procedures anchor much of the CDMO orthopedic market, several faster-moving areas are redefining what OEMs expect from their partners. Polaris Market Research projects the global market to reach USD 18.10 billion by 2034, from USD 8.48 billion in 2024, at a CAGR of 7.90% from 2025 to 2034. Within that outlook, spinal technologies, regenerative materials, regulatory complexity, and regional manufacturing strategies are shaping how contracts are won and delivered.

Spinal Surgery Is Positioned for Robust Growth

The spinal surgery application segment is projected to grow at a robust pace and is expected to witness the fastest growth during the forecast period. Polaris links this to the growing incidence of degenerative disc diseases, spinal deformities, and trauma-related spine injuries, alongside advances in minimally invasive and motion-preserving procedures. Companies developing interbody fusion devices, pedicle screw systems, and dynamic stabilization implants increasingly seek CDMOs with capabilities in biologic integration, polymer-metal hybrid constructs, and sterilization validation. The shift toward outpatient procedures and personalized solutions intensifies demand for rapid development cycles and scalable production, which is why spinal implants remain a strategic category for outsourced partners.

Orthobiologics and Regenerative Medicine

By device type, orthopedic implants dominated in 2024, while the orthobiologics segment is projected to grow at a robust pace in the coming years. Interest is rising in regenerative approaches that promote natural healing of bone and tissue. Orthobiologics, including bone graft substitutes, platelet-rich plasma (PRP), and stem cell-based materials, are gaining traction in both trauma and sports medicine applications. Specialized facilities and stringent quality controls are required for biologics production, and these needs are expected to keep driving outsourcing, particularly as regulatory pathways for advanced therapies become more streamlined.

Material Choices: Metallic and Polymeric

By material type, the market is segmented into metallic, polymeric, and others. The metallic segment accounted for a major revenue share in 2024 because of the widespread use of titanium alloys, stainless steel, and cobalt-chromium in joint replacements, fixation plates, and spinal devices. These materials offer strength, durability, and biocompatibility, making them well suited to load-bearing uses. The growing adoption of additive manufacturing for custom metallic implants has further accelerated the segment’s growth.

Europe: Compliance as a Reason to Partner

Europe is projected to hold a substantial revenue share in 2034, supported by an aging population, rising joint replacement surgeries, and government support for advanced medical technologies. The EU’s Medical Device Regulation has increased compliance complexity, prompting orthopedic companies to rely on CDMOs with regulatory expertise. Germany, France, and the UK are key contributors. Germany is described as a major hub for orthopedic CDMO demand, thanks to its strong medical technology sector, high volume of knee and hip replacements, and emphasis on precision engineering and automation in implant production.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/cdmo-orthopedic-market 

Asia Pacific: An Attractive Outsourcing Destination

Asia Pacific is expected to register the highest CAGR from 2025 to 2034, owing to rising healthcare expenditure, increasing orthopedic surgeries, and expanding medical tourism in countries such as India, China, and South Korea. Lower manufacturing costs and skilled labor make the region an appealing base for global companies pursuing orthopedic outsourcing. A growing middle-class population and improving healthcare infrastructure are boosting demand for joint replacements and trauma devices, while governments are supporting local manufacturing and encouraging CDMO partnerships that meet international quality standards.

Key Players and Recent Developments

Polaris identifies Elos Medtech, Intech Medical, Integer Holdings Corporation, Jabil Healthcare, Millstone Medical Outsourcing, Orchid Orthopedic Solutions, SpiTrex, Tecomet Inc., Tegra Medical, and Viant Medical among the key players. In July 2025, Straits Orthopaedics announced the completion of its acquisition of Medin Technologies, a U.S.-based manufacturer of sterilization cases and trays for the orthopedic industry, with operations in Totowa, New Jersey, and Manchester, New Hampshire.

Conclusion

The CDMO orthopedic market is positioned for growth as medical device manufacturers increasingly rely on specialized partners for product development and manufacturing. Rising demand for orthopedic implants, surgical instruments, and advanced joint reconstruction solutions is supporting outsourcing opportunities. Increasing adoption of minimally invasive procedures and technologically advanced medical devices is creating demand for precision manufacturing capabilities. Contract development and manufacturing organizations can benefit from investments in automation, quality control, and regulatory compliance. Strategic collaborations between medical device companies and CDMOs are also expected to support innovation and production efficiency. The market's future will depend on manufacturing expertise, cost optimization, and the ability to meet evolving healthcare requirements.

More Trending Latest Reports By Polaris Market Research:

Low Alcohol Beverage Market

Prostaglandin Analogs Market

Manual Resuscitators Market

Cell & Gene Therapy Bioanalytical Testing Services Market

Prostaglandin Analogs Market

Platelet Rich Plasma (PRP) Market

ISOBUS Component Market

Increased Prevalence of Burn Injuries Globally to Fuel Market Growth

Yarrow Market